- The Weed Blog https://www.theweedblog.com

FDA Says Yes to Marijuana for PTSD Study

2
Share.

Sent to me by SF ASA:

FDA Says Yes to Marijuana for PTSD Study:
MAPS E-Mail Newsletter
May 9, 2011

Welcome to the May 2011 edition of the MAPS E-mail Newsletter.

 

On April 28, 2011, the Food and Drug Administration approved our planned study of marijuana for PTSD in veterans of war. This is a historic first for medical marijuana research, being the first time the FDA has approved an outpatient marijuana study. The next step is to convince the National Institute on Drug Abuse–a very different agency with explicitly political motivations and a monopoly on marijuana for research–to sell us the marijuana we need to conduct the study.

Meanwhile, our MDMA-assisted psychotherapy for PTSD research program is charging ahead. We’re intensifying our fundraising efforts, expanding our range of research projects, and developing the world’s first training program in psychedelic therapy.

I’ve lost count of how many committed and talented people have contacted MAPS to request information about how they can receive training in psychedelic therapy. A few times, I’ve had the privilege of meeting them in person. I’ve witnessed firsthand the hope and dedication in their eyes when they ask how they can help MAPS bring psychedelic healing to those traumatized by violence and disease.

As we prepare to move to the next phase of our drug development program, there will be more need for therapists trained in MAPS’ approach to MDMA-assisted psychotherapy than ever before. And ultimately, the need for these skills will go far beyond the narrow context of clinical research. The establishment of legal psychedelic therapy clinics in the U.S. and elsewhere will require an entirely new generation of medical professionals trained in the techniques of psychedelic therapy.

We’re planning not just for the future of MAPS, but for the future of psychedelic medicine worldwide.

Since 1986, MAPS has distributed over $12 million to psychedelic and medical marijuana research and education–every dollar of which has come from our members. Please donate today and help us share this knowledge with the next generation of healers.

Finally, I’m delighted to announce that the Spring 2011 Special Edition of the MAPS Bulletin on “Psychedelics and the Mind/Body Connection” is now available online and in members’ mailboxes. With breathtaking visionary artwork and dozens of thought-provoking articles on everything from immunology and neuroscience to surfing and skydiving, this issue is sure to inspire.

Sincerely,

Brad Burge, M.A.
MAPS Director of Communications

Share.

About Author

2 Comments

  1. Daniel Kush on

    Yes, that is my real name. No, I’m not a stoner, per se. I am currently off duty from the Fire Department for PTSD symptoms. I had a nervous breakdown as a result of the intense stressors of my job as a paramedic/firefighter. I had used marijuana “legally, having obtained a doctors referral and the symptoms were greatly reduced. However, my job now knows that I have used it and I am very fearful to return to work. I know I will be tested. Meanwhile, I’ve been off work for the last 2 months and they have been horrible. Nightmares, constant memories of sorrow, pain and human suffering, horrible anxiety, and depression. These all have returned as I’ve promised my wife I won’t use it anymore. But here’s the thing: It is the only thing that works! Please keep me informed regarding the results of this study. I’m caught between a rock and a hard place as I can’t use pot, but I have to go back to work to provide for my family. I’m really having a hard time with this. I hope this study helps show that Marijuana is very helpful for those who have exceptionally stressful jobs. Thanks for reading.

  2. I don’t get why the FDA and NIDA allow for the study of psilocybin mushrooms, but not cannabis. Don’t they know mushrooms are the very drug that will destroy government?

Leave A Reply